Thyrocare Technologies Limited, a leading healthcare diagnostics company, has appointed Rajdeep Panwar as its Chief Commercial Officer (CCO), strengthening Thyrocare's leadership team as the company sharpens its commercial strategy and customer focus across India.

Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector. He brings extensive experience in P&L management, multi-market business expansion, strategic planning and scaling large, multi-centre diagnostic operations. Over the course of his career, he has been involved in the launch and management of more than 200 diagnostic laboratories and has been a founding team member of two healthcare ventures.

Prior to this, Rajdeep served as the Director at GHL Pharma & Diagnostics Ltd. (GHL–Medanta), where he played a key role in expanding Medanta Labs across North India. His professional journey also includes leadership roles at organisations such as Apollo Diagnostics, Johnson & Johnson, and Dr. Lal PathLabs, where he led initiatives spanning business expansion, commercial strategy, technical operations, customer support, process excellence, accreditation, and organisational transformation.

In his new role as Chief Commercial Officer, Rajdeep will be responsible for P&L of Thyrocare and lead the company’s commercial functions end-to-end, which include franchise business, corporate business, direct-to-consumer channels, customer relationship management, customer operations, catalogue management, and radiology services.  He will focus on driving revenue growth, enhancing customer experience, and expanding Thyrocare's presence across India.